title: Resolution of severe MMF-related gastrointestinal adverse events following conversion to enteric-coated mycophenolate sodium.
authors.forename: Barbara
authors.initials: B
authors.lastname: Suwelack
authors.forename: Gert
authors.initials: G
authors.lastname: Gabriels
authors.forename: Sabine
authors.initials: S
authors.lastname: Volmer
authors.forename: Uta
authors.initials: U
authors.lastname: Hillebrand
authors.forename: Helge
authors.initials: H
authors.lastname: Hohage
authors.forename: Thorsten
authors.initials: T
authors.lastname: Pohle
mesh_terms: D000328:Adult; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D009173:Mycophenolic Acid / Q000008:administration & dosage* / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000494:pharmacology*; D013276:Stomach Ulcer / Q000139:chemically induced* / Q000473:pathology*
chemical_list: D009173:Mycophenolic Acid